BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,220,660

« Back to Dashboard

Summary for Patent: 4,220,660

Title: Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
Abstract:The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a mercapto alkane sulfonic acid having the general formula to the human treated with the cytostatically active alkylating agent, in an amount ranging from 20% of the weight of the alkylating agent to the highest tolerated dosage of the salt of the mercapto alkane sulfonic acid, simultaneously or separately in combination with the alkylating agent.
Inventor(s): Brock; Norbert (Bielefeld, DE)
Assignee: Asta-werke Aktiengesellschaft, Chemische Farik (Bielefeld, DE)
Application Number:05/967,000
Patent Claim Types:
see list of patent claims
Use; Compound;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,220,660

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2756018Dec 14, 1977
Germany2827625Jun 23, 1978

International Patent Family for Patent: 4,220,660

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office0002495► Subscribe
Egypt14057► Subscribe
Denmark154608► Subscribe
Denmark553978► Subscribe
Germany2756018► Subscribe
German Democratic Republic140420► Subscribe
Canada1117015► Subscribe
Austria358162► Subscribe
Finland783756► Subscribe
AustriaA871078► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus